Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Grey matter pathology in multiple sclerosis.
Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, Cavalla P. Vercellino M, et al. Among authors: cavalla p. J Neuropathol Exp Neurol. 2005 Dec;64(12):1101-7. doi: 10.1097/01.jnen.0000190067.20935.42. J Neuropathol Exp Neurol. 2005. PMID: 16319720
Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
Vercellino M, Merola A, Piacentino C, Votta B, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P. Vercellino M, et al. Among authors: cavalla p. J Neuropathol Exp Neurol. 2007 Aug;66(8):732-9. doi: 10.1097/nen.0b013e31812571b0. J Neuropathol Exp Neurol. 2007. PMID: 17882017
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience.
Ghezzi A, Amato MP, Annovazzi P, Capobianco M, Gallo P, La Mantia L, Marrosu MG, Martinelli V, Milani N, Moiola L, Patti F, Pozzilli C, Trojano M, Zaffaroni M, Comi G; ITEMS (Immunomodulatory Treatment of Early-onset MS) Group. Ghezzi A, et al. Neurol Sci. 2009 Jun;30(3):193-9. doi: 10.1007/s10072-009-0083-1. Epub 2009 Apr 22. Neurol Sci. 2009. PMID: 19387545 Clinical Trial.
Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males.
Fenoglio C, Scalabrini D, Esposito F, Comi C, Cavalla P, De Riz M, Martinelli V, Piccio LM, Venturelli E, Fumagalli G, Capra R, Collimedaglia L, Ghezzi A, Rodegher ME, Vercellino M, Leone M, Giordana MT, Bresolin N, Monaco F, Comi G, Scarpini E, Martinelli-Boneschi F, Galimberti D. Fenoglio C, et al. Among authors: cavalla p. Genes Immun. 2010 Sep;11(6):497-503. doi: 10.1038/gene.2010.18. Epub 2010 May 13. Genes Immun. 2010. PMID: 20463744
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis.
Amato MP, Portaccio E, Ghezzi A, Hakiki B, Zipoli V, Martinelli V, Moiola L, Patti F, La Mantia L, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, Di Tommaso V, Paolicelli D, Marrosu MG, Comi G, Pellegrini F, Trojano M; MS Study Group of the Italian Neurological Society. Amato MP, et al. Neurology. 2010 Nov 16;75(20):1794-802. doi: 10.1212/WNL.0b013e3181fd62bb. Neurology. 2010. PMID: 21079181
Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis.
Vercellino M, Grifoni S, Romagnolo A, Masera S, Mattioda A, Trebini C, Chiavazza C, Caligiana L, Capello E, Mancardi GL, Giobbe D, Mutani R, Giordana MT, Cavalla P. Vercellino M, et al. Among authors: cavalla p. Mult Scler. 2011 Oct;17(10):1194-201. doi: 10.1177/1352458511406164. Epub 2011 May 25. Mult Scler. 2011. PMID: 21613335 Free article.
180 results